In adolescents and Grownups, Szefler et al showed the addition of FeNO measurement being an indicator of asthma control resulted in larger doses of ICS and extensive-acting ?two agonists than did normal guideline-centered therapy, and didn't decide advancements in asthma signs or symptoms or lung function [a hundred and five]. A the latest meta-Exa